|
|
Volumn 350, Issue , 2015, Pages h2734-
|
|
Margaret McCartney: Second use patents--why do we have to prescribe branded Lyrica for pain?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ANALGESIC AGENT;
PREGABALIN;
ANALOGS AND DERIVATIVES;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE DELIVERY;
HEALTH CARE QUALITY;
HUMAN;
PAIN;
PRESCRIPTION;
TRENDS;
UNITED KINGDOM;
ANALGESICS;
COST-BENEFIT ANALYSIS;
DELIVERY OF HEALTH CARE;
DRUG INDUSTRY;
DRUG PRESCRIPTIONS;
GAMMA-AMINOBUTYRIC ACID;
GREAT BRITAIN;
HUMANS;
PAIN;
PHYSICIAN'S PRACTICE PATTERNS;
QUALITY OF HEALTH CARE;
|
|
EID: 84939431078
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.h2734 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|